Brain

Werth Family Investment Associates Converts $5.8 Million of Debt into Cingulate Equity at a Premium

Conversion Follows $1.0 Million Capital Investment in August 2023KANSAS CITY, Kan., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:…

1 year ago

CENTR Launches Enhanced Gut Health and Cognitive Performance Drinks on Amazon.com

Vancouver, British Columbia--(Newsfile Corp. - September 8, 2023) - CENTR Brands Corp. (CSE: CNTR)  (FSE: 303) (OTCQB: CNTRF) ("CENTR" or…

1 year ago

Hyperfine, Inc. to Present at Gilmartin Group Emerging Growth Showcase

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world’s first FDA-cleared…

1 year ago

SeatMatch Unveils Industry’s First Neural Network Mapping Recruitment Technology

Innovative recruiting and hiring company leverages new Neural Network Mapping technology of the human brain to increase success rates in…

1 year ago

TeraRecon Applauded by Frost & Sullivan for Solving Time-related Challenges in Neurological Care and Its Market-leading Position

TeraRecon partners with different vendors to provide precise, AI-supported patient care and expand in the neurological solutions market and other…

1 year ago

Fortifeye Vitamins Introduces rTG Omgea 3 Fish Oil, a Revolutionary Leap Forward in Nutritional Health

Fortifeye Vitamins - Introducing rTG Omega 3 Fish OilOCALA, FL / ACCESSWIRE / September 7, 2023 / In a groundbreaking…

1 year ago

Lexicon Announces Series of Presentations Relating to LX9211, Its Investigational Drug for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)

Five upcoming scientific presentations will add to the body of evidence supporting the advancement of LX9211 into late-stage development Phase…

1 year ago

BioVie Hosting Virtual KOL Event on NE3107 in Alzheimer’s Disease Today, September 7, 2023

CARSON CITY, Nev., Sept. 07, 2023 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company…

1 year ago

Elicio Therapeutics Receives $2.6 Million Grant from the Gastro-Intestinal (GI) Research Foundation to Fund Research for Two Therapeutic Cancer Vaccines

Funds will advance research into ELI-007, a mutant BRAF-peptide vaccine, and ELI-008, a p53 hotspot mutation-peptide vaccine, with the aim…

1 year ago